Meth Addiction Help

January 24, 2007--11:45 a.m.  CST

DALLAS, TX--Tens of thousands of people are dealing an addiction to methamphetamine every single day, but there's a new treatment that could help them kick the habit for good.  It's a program run by Dr. Harold Urschel called the PROMETATM Protocol and uses a cocktail of three FDA approved drugs being used off label to treat meth addiction.

To contact Dr. Urschel directly or find out more about his addiction treatment, please go to

To find out more about the PROMETATM treatmenet for methamphetamine, cocaine or alcohol, or to find out more about Dr. Urschel's research study on methamphetamine addiction using the PROMETATM treatment protocols, please go to

The CNS Research Group is headed by Dr. Harold Urschel who specializes in chemical dependency (addiction) and general psychiatry. Dr. Urschel graduated from Princeton University with a degree in neuropsychology and received his medical degree from The University of Texas Southwestern Medical School in Dallas, Texas. He is a Diplomate in Psychiatry and Addiction Psychiatry certified by the American Board of Psychiatry and Neurology. Dr. Urschel founded the Chemical Dependency Recovery Services program at St. Paul University Hospital in 1999, which he has served as Medical Director. He has considerable experience with clinical research trials including participation in 12 national multi-site trials in chemical dependency and general psychiatric research. Drawing from a wide-ranging referral network of private physicians and community agencies as well as local and national media relationships, Dr. Urschel has consistently been among the leading recruiting sites nationwide in addiction trials.

For information about upcoming clinical trials go to

Dr. Urschel has partnered with specialists in a wide range of clinical research areas in psychiatry and neurology, bringing a wealth of clinical and research expertise for any specific trial within the CNS domain. These include inpatient and outpatient psychiatric trials in depression, anxiety, bipolar disorder, and schizophrenia. The CNS Research Group also provides significant expertise with general neurological disorders including Alzheimer's, Parkinson's, neuralgia, headaches, and epilepsy.